BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 21544326)

  • 1. Role of HPV in tumorigenesis of oral keratinocytes.
    Gujuluva C; Shin K; Park N
    Int J Oncol; 1996 Jan; 8(1):21-8. PubMed ID: 21544326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenic transformation of HPV-immortalized human oral keratinocytes is associated with the genetic instability of cells.
    Shin KH; Tannyhill RJ; Liu X; Park NH
    Oncogene; 1996 Mar; 12(5):1089-96. PubMed ID: 8649801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of UV-irradiation on cell cycle, viability and the expression of p53, gadd153 and gadd45 genes in normal and HPV-immortalized human oral keratinocytes.
    Gujuluva CN; Baek JH; Shin KH; Cherrick HM; Park NH
    Oncogene; 1994 Jul; 9(7):1819-27. PubMed ID: 8208528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of actinomycin-d on the cell-cycle progression and the expression of p53, waf1/cip1, gadd45, and mdm-2 genes in human oral keratinocytes - implication of human papillomavirus infection.
    Baek J; Gujuluva C; Shin K; Park N
    Int J Oncol; 1994 Nov; 5(5):1023-30. PubMed ID: 21559675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV-16 oncogenes E6 and E7 are mutagenic in normal human oral keratinocytes.
    Liu X; Han S; Baluda MA; Park NH
    Oncogene; 1997 May; 14(19):2347-53. PubMed ID: 9178911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basic fibroblast growth factor causes growth arrest in MCF-7 human breast cancer cells while inducing both mitogenic and inhibitory G1 events.
    Wang H; Rubin M; Fenig E; DeBlasio A; Mendelsohn J; Yahalom J; Wieder R
    Cancer Res; 1997 May; 57(9):1750-7. PubMed ID: 9135019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
    Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent iron chelators increase the mRNA levels of the universal cyclin-dependent kinase inhibitor p21(CIP1/WAF1), but paradoxically inhibit its translation: a potential mechanism of cell cycle dysregulation.
    Le NT; Richardson DR
    Carcinogenesis; 2003 Jun; 24(6):1045-58. PubMed ID: 12807743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient down-regulation of cyclin A-associated activity and expression in suspended primary keratinocytes requires p21(Cip1).
    Hauser P; Ma L; Agrawal D; Haura E; Cress WD; Pledger WJ
    Mol Cancer Res; 2004 Feb; 2(2):96-104. PubMed ID: 14985466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor beta 1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells.
    Gong J; Ammanamanchi S; Ko TC; Brattain MG
    Cancer Res; 2003 Jun; 63(12):3340-6. PubMed ID: 12810668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
    Yin MB; Guo B; Panadero A; Frank C; Wrzosek C; Slocum HK; Rustum YM
    Exp Cell Res; 1999 Feb; 247(1):189-99. PubMed ID: 10047461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes.
    Nahum A; Hirsch K; Danilenko M; Watts CK; Prall OW; Levy J; Sharoni Y
    Oncogene; 2001 Jun; 20(26):3428-36. PubMed ID: 11423993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between polymorphism in p21(Waf1/Cip1) cyclin-dependent kinase inhibitor gene and human oral cancer.
    Ralhan R; Agarwal S; Mathur M; Wasylyk B; Srivastava A
    Clin Cancer Res; 2000 Jun; 6(6):2440-7. PubMed ID: 10873097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21.
    Li Y; Jenkins CW; Nichols MA; Xiong Y
    Oncogene; 1994 Aug; 9(8):2261-8. PubMed ID: 7913544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperoxia induces S-phase cell-cycle arrest and p21(Cip1/Waf1)-independent Cdk2 inhibition in human carcinoma T47D-H3 cells.
    Bilodeau JF; Faure R; Piedboeuf B; Mirault ME
    Exp Cell Res; 2000 May; 256(2):347-57. PubMed ID: 10772807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth inhibition by the muscarinic M(3) acetylcholine receptor: evidence for p21(Cip1/Waf1) involvement in G(1) arrest.
    Burdon D; Patel R; Challiss RA; Blank JL
    Biochem J; 2002 Oct; 367(Pt 2):549-59. PubMed ID: 12126481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cell cycle, wild-type p53 and DNA damage on p21CIP1/Waf1 expression in human breast epithelial cells.
    Gudas J; Nguyen H; Li T; Hill D; Cowan KH
    Oncogene; 1995 Jul; 11(2):253-61. PubMed ID: 7624142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.
    Huang S; Liu LN; Hosoi H; Dilling MB; Shikata T; Houghton PJ
    Cancer Res; 2001 Apr; 61(8):3373-81. PubMed ID: 11309295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirements for p53 and the ATM gene product in the regulation of G1/S and S phase checkpoints.
    Xie G; Habbersett RC; Jia Y; Peterson SR; Lehnert BE; Bradbury EM; D'Anna JA
    Oncogene; 1998 Feb; 16(6):721-36. PubMed ID: 9488036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deregulation of p53/p21Cip1/Waf1 pathway contributes to polyploidy and apoptosis of E1A+cHa-ras transformed cells after gamma-irradiation.
    Bulavin DV; Tararova ND; Aksenov ND; Pospelov VA; Pospelova TV
    Oncogene; 1999 Oct; 18(41):5611-9. PubMed ID: 10523840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.